Arkolith/Insider Trading/NKTR/Form 4

Robin Howard W

President & CEO, DirectorNEKTAR THERAPEUTICS (NKTR) · full profile →Form 4 · filed Aug 21, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$42K
Net Open-Market Flow
-$42K
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 19, 2025Sell(S)2K$26.59$42K69K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 19, 2025Grant(A)87K—$087K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-110773) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML